Mark Kačar

2.5k total citations
14 papers, 142 citations indexed

About

Mark Kačar is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Mark Kačar has authored 14 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Rheumatology. Recurrent topics in Mark Kačar's work include Inflammasome and immune disorders (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Otitis Media and Relapsing Polychondritis (3 papers). Mark Kačar is often cited by papers focused on Inflammasome and immune disorders (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Otitis Media and Relapsing Polychondritis (3 papers). Mark Kačar collaborates with scholars based in United Kingdom, Slovenia and Belgium. Mark Kačar's co-authors include Sinisa Savic, Jeroen C.H. van der Hilst, Peter Korošec, Shelly Pathak, Matija Rijavec, Julij Šelb, Dennis McGonagle, Andrew Gough, John Fitton and Maya H Buch and has published in prestigious journals such as Frontiers in Immunology, Lara D. Veeken and Clinical & Experimental Allergy.

In The Last Decade

Mark Kačar

14 papers receiving 140 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Kačar United Kingdom 7 71 64 50 34 22 14 142
Prashantha Vaitla United Kingdom 3 50 0.7× 70 1.1× 31 0.6× 27 0.8× 6 0.3× 4 101
Erika Van Nieuwenhove Belgium 8 59 0.8× 53 0.8× 21 0.4× 34 1.0× 5 0.2× 13 132
Marlen Oswald United Kingdom 2 62 0.9× 115 1.8× 35 0.7× 34 1.0× 2 0.1× 2 136
Márta Bocskai Hungary 6 35 0.5× 27 0.4× 11 0.2× 46 1.4× 8 0.4× 7 127
Raphael Escaig Germany 5 37 0.5× 34 0.5× 59 1.2× 5 0.1× 7 0.3× 7 124
L. Lamm Denmark 7 98 1.4× 24 0.4× 35 0.7× 22 0.6× 4 0.2× 12 183
Rémi Pescarmona France 6 57 0.8× 29 0.5× 19 0.4× 25 0.7× 3 0.1× 11 142
Elvira Mora Spain 7 25 0.4× 13 0.2× 25 0.5× 37 1.1× 10 0.5× 24 121
Amanda Duhlin Sweden 5 135 1.9× 78 1.2× 6 0.1× 41 1.2× 16 0.7× 6 216

Countries citing papers authored by Mark Kačar

Since Specialization
Citations

This map shows the geographic impact of Mark Kačar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kačar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kačar more than expected).

Fields of papers citing papers by Mark Kačar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kačar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kačar. The network helps show where Mark Kačar may publish in the future.

Co-authorship network of co-authors of Mark Kačar

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kačar. A scholar is included among the top collaborators of Mark Kačar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kačar. Mark Kačar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bizjak, Mojca, Olivier Aerts, David Pesqué, et al.. (2025). Contact Urticaria and Related Conditions: Clinical Review. Contact Dermatitis. 93(2). 87–107. 4 indexed citations
2.
Kačar, Mark, et al.. (2024). The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review. Journal of Clinical Medicine. 13(6). 1717–1717. 1 indexed citations
3.
Kačar, Mark, et al.. (2024). Sequelae of B-Cell Depleting Therapy: An Immunologist’s Perspective. BioDrugs. 39(1). 103–130. 1 indexed citations
4.
Kačar, Mark, Matija Rijavec, Julij Šelb, & Peter Korošec. (2023). Clonal mast cell disorders and hereditary α‐tryptasemia as risk factors for anaphylaxis. Clinical & Experimental Allergy. 53(4). 392–404. 24 indexed citations
5.
Rozman, Aleš, et al.. (2022). Length of hospital stay and survival of hospitalized COVID-19 patients during the second wave of the pandemic: A single centre retrospective study from Slovenia. Slovenian Journal of Public Health. 61(4). 201–208. 1 indexed citations
6.
Kačar, Mark, Gašper Markelj, & Tadej Avčin. (2022). Autoimmune and autoinflammatory manifestations in inborn errors of immunity. Current Opinion in Allergy and Clinical Immunology. 22(6). 343–351. 3 indexed citations
7.
Watad, ‬‬‬‬Abdulla, Mark Kačar, Nicola Luigi Bragazzi, et al.. (2021). Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication. Frontiers in Immunology. 12. 610019–610019. 21 indexed citations
8.
Nieuwenhove, Erika Van, Ellen De Langhe, James Dooley, et al.. (2021). Phenotypic analysis of pyrin-associated autoinflammation with neutrophilic dermatosis patients during treatment. Lara D. Veeken. 60(11). 5436–5446. 7 indexed citations
9.
Lara‐Reyna, Samuel, James A. Poulter, Elton J. R. Vasconcelos, et al.. (2020). Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease. Journal of Clinical Immunology. 41(2). 441–457. 4 indexed citations
10.
Kačar, Mark, John Fitton, Andrew Gough, et al.. (2020). Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease. RMD Open. 6(2). e001246–e001246. 23 indexed citations
11.
Pathak, Shelly, Dorota Rowczenio, Samuel Lara‐Reyna, et al.. (2020). Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler Syndrome. Frontiers in Immunology. 11. 569006–569006. 8 indexed citations
12.
Kačar, Mark, Sinisa Savic, & Jeroen C.H. van der Hilst. (2020). <p>The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature</p>. Journal of Inflammation Research. Volume 13. 141–149. 24 indexed citations
13.
Kačar, Mark, Shelly Pathak, & Sinisa Savic. (2019). Hereditary systemic autoinflammatory diseases and Schnitzler’s syndrome. Lara D. Veeken. 58(Supplement_6). vi31–vi43. 16 indexed citations
14.
Kačar, Mark, et al.. (2018). Selective Response to Omalizumab in a Patient With Concomitant ncMCAS and POTS: What Does it Teach us About the Underlying Disease?. Journal of Investigational Allergology and Clinical Immunology. 28(4). 261–263. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prashantha Vaitla Breakdown of academic impact, for papers by Erika Van Nieuwenhove Breakdown of academic impact, for papers by Marlen Oswald Breakdown of academic impact, for papers by Márta Bocskai Breakdown of academic impact, for papers by Raphael Escaig Breakdown of academic impact, for papers by L. Lamm Breakdown of academic impact, for papers by Rémi Pescarmona Breakdown of academic impact, for papers by Elvira Mora Breakdown of academic impact, for papers by Amanda Duhlin
Rankless by CCL
2026